These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33732206)

  • 61. Late-onset Pompe disease in a 54 year-old sportsman with an episode of syncope: a case report.
    Walczak-Galezewska M; Skrypnik D; Szulinska M; Musialik K; Skrypnik K; Bogdanski P
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3665-3667. PubMed ID: 28925476
    [TBL] [Abstract][Full Text] [Related]  

  • 62. High prevalence of paraspinal muscle involvement in adults with McArdle disease.
    Álvarez-Velasco R; Nuñez-Peralta CA; Alonso-Pérez J; Gallardo E; Collet-Vidiella R; Reyes-Leiva D; Pascual-Goñi E; Martín-Aguilar L; Caballero-Ávila M; Carbayo-Viejo Á; Llauger-Roselló J; Díaz-Manera J; Olivé M
    Muscle Nerve; 2022 May; 65(5):568-573. PubMed ID: 35174518
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High-risk screening of late-onset Pompe disease: A different early portrait in China.
    Jiao K; Dong J; Luo S; Yu L; Ke Q; Wang Z; Luan X; Zhang X; Guo J; Chen Y; Li X; Tan S; Qian F; Jiang J; Yu X; Yue D; Liu C; Luo L; Li J; Qu Y; Chen L; Tu J; Sun C; Yan C; Song J; Xi J; Lin J; Lu J; Zhao C; Zhu W; Fang Q
    Front Neurol; 2022; 13():965207. PubMed ID: 36237614
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multisystem late onset Pompe disease (LOPD): an update on clinical aspects.
    Toscano A; Rodolico C; Musumeci O
    Ann Transl Med; 2019 Jul; 7(13):284. PubMed ID: 31392196
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Motor function and respiratory capacity in patients with late-onset pompe disease.
    Illes Z; Mike A; Trauninger A; Várdi K; Váczi M
    Muscle Nerve; 2014 Apr; 49(4):603-6. PubMed ID: 24375171
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A molecular analysis of the GAA gene and clinical spectrum in 38 patients with Pompe disease in Japan.
    Fukuhara Y; Fuji N; Yamazaki N; Hirakiyama A; Kamioka T; Seo JH; Mashima R; Kosuga M; Okuyama T
    Mol Genet Metab Rep; 2018 Mar; 14():3-9. PubMed ID: 29124014
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group.
    Filosto M; Cotti Piccinelli S; Ravaglia S; Servidei S; Moggio M; Musumeci O; Donati MA; Pegoraro E; Di Muzio A; Maggi L; Tonin P; Marrosu G; Sancricca C; Lerario A; Sacchini M; Semplicini C; Bozzoni V; Telese R; Bonanno S; Piras R; Maioli MA; Ricci G; Vercelli L; Galvagni A; Gallo Cassarino S; Caria F; Mongini T; Siciliano G; Padovani A; Toscano A
    Adv Ther; 2019 May; 36(5):1177-1189. PubMed ID: 30879255
    [TBL] [Abstract][Full Text] [Related]  

  • 68. 3D analysis of the chest wall motion for monitoring late-onset Pompe disease patients.
    Meric H; Falaize L; Pradon D; Orlikowski D; Prigent H; Lofaso F
    Neuromuscul Disord; 2016 Feb; 26(2):146-52. PubMed ID: 26711305
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Severe Cardiomyopathy as the Isolated Presenting Feature in an Adult with Late-Onset Pompe Disease: A Case Report.
    Mori M; Bailey LA; Estrada J; Rehder CW; Li JS; Rogers JG; Bali DS; Buckley AF; Kishnani PS
    JIMD Rep; 2017; 31():79-83. PubMed ID: 27142047
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Acute respiratory failure as presentation of late-onset Pompe disease complicating the diagnostic process as a labyrinth: a case report.
    Menzella F; Codeluppi L; Lusuardi M; Galeone C; Valzania F; Facciolongo N
    Multidiscip Respir Med; 2018; 13():32. PubMed ID: 30186604
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Muscle diffusion MRI reveals autophagic buildup in a mouse model for Pompe disease.
    Rohm M; Russo G; Helluy X; Froeling M; Umathum V; Südkamp N; Manahan-Vaughan D; Rehmann R; Forsting J; Jacobsen F; Roos A; Shin Y; Schänzer A; Vorgerd M; Schlaffke L
    Sci Rep; 2023 Dec; 13(1):22822. PubMed ID: 38129558
    [TBL] [Abstract][Full Text] [Related]  

  • 72. White matter lesions in treated late onset Pompe disease are not different to matched controls.
    Schneider I; Hensel O; Zierz S
    Mol Genet Metab; 2019 Jun; 127(2):128-131. PubMed ID: 31153821
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The impact of antibodies in late-onset Pompe disease: a case series and literature review.
    Patel TT; Banugaria SG; Case LE; Wenninger S; Schoser B; Kishnani PS
    Mol Genet Metab; 2012 Jul; 106(3):301-9. PubMed ID: 22613277
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Urodynamic and clinical studies in patients with late-onset Pompe disease and lower urinary tract symptoms.
    Kuchenbecker KS; Kirschner-Hermanns R; Kornblum C; Jaekel A; Anding R; Kohler A
    Neurourol Urodyn; 2020 Jun; 39(5):1437-1446. PubMed ID: 32343026
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Autopsy findings in late-onset Pompe disease: a case report and systematic review of the literature.
    Hobson-Webb LD; Proia AD; Thurberg BL; Banugaria S; Prater SN; Kishnani PS
    Mol Genet Metab; 2012 Aug; 106(4):462-9. PubMed ID: 22664150
    [TBL] [Abstract][Full Text] [Related]  

  • 76. MRI of trunk muscles and motor and respiratory function in patients with myotonic dystrophy type 1.
    Solbakken G; Bjørnarå B; Kirkhus E; Nguyen B; Hansen G; Frich JC; Ørstavik K
    BMC Neurol; 2019 Jun; 19(1):135. PubMed ID: 31216995
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Muscle MRI of classic infantile pompe patients: Fatty substitution and edema-like changes.
    Pichiecchio A; Rossi M; Cinnante C; Colafati GS; De Icco R; Parini R; Menni F; Furlan F; Burlina A; Sacchini M; Donati MA; Fecarotta S; Casa RD; Deodato F; Taurisano R; Di Rocco M
    Muscle Nerve; 2017 Jun; 55(6):841-848. PubMed ID: 27668838
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diaphragm pacing and independent breathing in individuals with severe Pompe disease.
    Liberati C; Byrne BJ; Fuller DD; Croft C; Pitts T; Ehrbar J; Leon-Astudillo C; Smith BK
    Front Rehabil Sci; 2023; 4():1184031. PubMed ID: 37583873
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gene Therapy for Pompe Disease: The Time is now.
    Colella P; Mingozzi F
    Hum Gene Ther; 2019 Oct; 30(10):1245-1262. PubMed ID: 31298581
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing.
    Lévesque S; Auray-Blais C; Gravel E; Boutin M; Dempsey-Nunez L; Jacques PE; Chenier S; Larue S; Rioux MF; Al-Hertani W; Nadeau A; Mathieu J; Maranda B; Désilets V; Waters PJ; Keutzer J; Austin S; Kishnani P
    Orphanet J Rare Dis; 2016 Jan; 11():8. PubMed ID: 26809617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.